These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Therapy resistance of gastro-oesophageal reflux symptoms: acid reflux, non-acid reflux or no reflux]. Bredenoord AJ, Smout AJ. Ned Tijdschr Geneeskd; 2008 Nov 22; 152(47):2548-52. PubMed ID: 19174935 [Abstract] [Full Text] [Related]
27. Efficacy of three different dosages of esomeprazole in the long-term management of reflux disease: a prospective, randomized study, using the wireless Bravo pH system. Vasiliadis KV, Viazis N, Vlachogiannakos J, Sgouros SN, Stefanidis G, Archimandritis A, Karamanolis DG. Am J Gastroenterol; 2010 Feb 22; 105(2):308-13. PubMed ID: 19809412 [Abstract] [Full Text] [Related]
37. A COX-2-specific inhibitor plus a proton-pump inhibitor: is this a reasonable approach to reduction in NSAIDs' GI toxicity? Cryer B. Am J Gastroenterol; 2006 Apr 22; 101(4):711-3. PubMed ID: 16635218 [Abstract] [Full Text] [Related]
38. Is the use of esomeprazole in gastroesophageal reflux disease a cost-effective option in Poland? Petryszyn P, Staniak A, Grzegrzolka J. J Comp Eff Res; 2016 Mar 22; 5(2):169-78. PubMed ID: 26946951 [Abstract] [Full Text] [Related]